Prilenia develops innovative biopharmaceuticals aimed at treating neurodegenerative diseases, with a primary focus on pridopidine for conditions like ALS and Huntington’s disease. Our work is driven by the urgent need for effective therapies that can change lives and address significant unmet med...
